Clinical Trial Update: OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to evaluate glibenclamide for neuropathic pain in multiple sclerosis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neuropathic Pain

Drugs mentioned

• Glibenclamide (OER formulation) (Glibenclamide)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Multiple Sclerosis, Neuropathic Pain | Phase 1 | Status: NOT_YET_RECRUITING